TG Therapeutics, Inc.TGTXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P100
Near historical high
vs 2Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM21.80%+43.7%
202415.17%+35.8%
202311.17%+100.1%
2022-7651.92%-49.7%
2021-5112.41%+97.2%
2020-179393.42%-63.0%
2019-110067.11%+3.5%
2018-114075.00%-46.8%
2017-77695.82%-50.0%
2016-51782.05%-